Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. POM
POM logo

POM Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
0.400
Open
0.399
VWAP
0.38
Vol
1.13M
Mkt Cap
45.43M
Low
0.369
Amount
432.60K
EV/EBITDA(TTM)
--
Total Shares
119.19M
EV
366.54M
EV/OCF(TTM)
--
P/S(TTM)
--
PomDoctor Ltd is a company that mainly operates an online medical services platform for chronic diseases. The Company's business model focuses on chronic disease management and pharmaceutical services, forming a one-stop medical service platform that connects patients with doctors and pharmaceutical products. It helps patients to conveniently connect with doctors and obtain one-stop medical services.
Show More

Events Timeline

(ET)
2026-02-02
06:10:00
PomDoctor Receives Nasdaq Deficiency Notice
select
2025-12-10 (ET)
2025-12-10
09:40:00
Pepco Holdings Trading Halted Due to Volatility
select
2025-12-10
09:40:00
Pepco Holdings, Inc. Trading Resumes
select
2025-10-08 (ET)
2025-10-08
11:36:22
PomDoctor Debuts at $4.50 After IPO Set at $4.00 per Share
select
2025-10-08
08:03:04
PomDoctor Sets IPO Price at $4.00 for 5 Million Shares
select

News

PRnewswire
7.0
04-13PRnewswire
Reminder for PomDoctor Securities Class Action
  • Class Action Notice: Rosen Law Firm reminds investors who purchased PomDoctor Ltd. (NASDAQ:POM) securities between October 9, 2025, and December 11, 2025, to apply as lead plaintiffs by April 7, 2026, to participate in the class action and seek compensation.
  • Fee Arrangement: Investors joining the class action will incur no out-of-pocket costs, as the law firm operates on a contingency fee basis, thereby reducing the financial burden on investors.
  • Case Background: The lawsuit alleges that PomDoctor made false and misleading statements during the class period, involving fraudulent stock promotion schemes and insider trading through offshore accounts, resulting in investor losses.
  • Law Firm Credentials: Rosen Law Firm specializes in securities class actions and has achieved the largest securities class action settlement against a Chinese company, demonstrating its expertise and high success rate in this field.
PRnewswire
7.0
04-12PRnewswire
Investigation Launched into Pomdoctor Securities Litigation
  • Legal Investigation: Faruq & Faruq, LLP is investigating potential claims against Pomdoctor Limited and urges investors to contact them before the April 13, 2026 deadline to seek lead plaintiff status, ensuring their rights in the class action are protected.
  • Stock Price Plunge: Pomdoctor's stock price fell from approximately $0.50 on December 10, 2025, to about $0.38 the following day, representing a decline of roughly $0.12 or 24% in a single trading session, highlighting severe investor concerns regarding the company's financial performance.
  • False Promotion Allegations: The lawsuit alleges that Pomdoctor and its executives violated federal securities laws through social media misinformation and insider trading, leading to significant losses for investors and damaging the company's reputation and market trust.
  • Investor Rights Protection: Faruq & Faruq encourages anyone with information regarding Pomdoctor's conduct to come forward, including whistleblowers and former employees, to aid in the legal proceedings aimed at securing better outcomes for affected investors.
Globenewswire
7.0
04-12Globenewswire
PomDoctor Securities Class Action Reminder
  • Class Action Notice: Rosen Law Firm reminds investors who purchased PomDoctor Ltd. (NASDAQ: POM) securities between October 9 and December 11, 2025, to apply as lead plaintiffs by April 13, 2026, to participate in the class action and potentially receive compensation without upfront costs.
  • Lawsuit Background: The lawsuit alleges that PomDoctor made false and misleading statements during the class period, failing to disclose a fraudulent stock promotion scheme involving social media, which led to investor losses during a price manipulation campaign, thereby damaging the company's reputation and market trust.
  • Law Firm Credentials: Rosen Law Firm specializes in securities class actions, having recovered over $438 million for investors in 2019 alone, and achieved the largest securities class action settlement against a Chinese company in 2017, highlighting its leadership and success in the industry.
  • Investor Guidance: The firm advises investors to select qualified counsel with a proven track record to avoid firms that merely act as intermediaries, ensuring effective legal representation and support in litigation.
Globenewswire
7.0
04-10Globenewswire
PomDoctor Faces Class Action Lawsuit Over Securities Fraud Allegations
  • Class Action Initiated: Bronstein, Gewirtz & Grossman, LLC has announced a class action lawsuit against PomDoctor, seeking damages for investors who purchased securities between October 9 and December 11, 2025, reflecting strong investor concerns over potential fraud.
  • Allegations of False Statements: The complaint alleges that PomDoctor failed to disclose significant adverse facts regarding its business and operations during the class period, misleading investors and highlighting severe deficiencies in corporate governance and transparency.
  • Insider Trading Activities: The lawsuit further claims that insiders used offshore or nominee accounts to facilitate coordinated share dumping during price inflation campaigns, revealing improper market manipulation that could undermine investor confidence.
  • Legal Implications for Investors: Investors must apply to be lead plaintiffs by April 6, 2026, indicating the urgency of the case, while Bronstein, Gewirtz & Grossman, LLC offers risk-free representation, emphasizing their commitment to protecting investor rights.
Globenewswire
7.0
04-09Globenewswire
Reminder for PomDoctor Securities Class Action
  • Class Action Notice: Rosen Law Firm reminds investors who purchased PomDoctor securities between October 9 and December 11, 2025, to apply as lead plaintiffs by April 13, 2026, to potentially receive compensation without any out-of-pocket costs.
  • Lawsuit Background: The lawsuit alleges that PomDoctor was involved in a fraudulent stock promotion scheme during the class period, utilizing social media to spread misinformation that misled investors and affected stock prices.
  • Law Firm Credentials: Rosen Law Firm specializes in securities class actions and has achieved the largest securities class action settlement against a Chinese company, being ranked first in 2017 for the number of settlements, showcasing its expertise and success in this field.
  • Investor Guidance: Investors are advised to carefully select law firms with proven success in leadership roles, avoiding those that merely act as intermediaries, to ensure effective legal representation in the class action.
PRnewswire
7.0
04-07PRnewswire
PomDoctor Securities Class Action Reminder
  • Class Action Notice: Rosen Law Firm reminds investors who purchased PomDoctor Ltd. (NASDAQ:POM) securities between October 9 and December 11, 2025, to apply as lead plaintiffs by April 7, 2026, to participate in the class action and seek compensation.
  • Fee Arrangement: Investors joining the class action will not incur any upfront costs, as the law firm operates on a contingency fee basis, which alleviates financial burdens and encourages more victims to participate.
  • Lawsuit Background: The lawsuit alleges that PomDoctor made false and misleading statements during the class period, involving fraudulent stock promotions and insiders manipulating stock prices through offshore accounts, resulting in significant losses for investors.
  • Law Firm's Advantage: Rosen Law Firm is renowned for its successful track record in securities class actions, having secured hundreds of millions in settlements, emphasizing the importance of selecting experienced counsel to protect investor rights.

Valuation Metrics

The current forward P/E ratio for PomDoctor Ltd (POM.O) is 0.00, compared to its 5-year average forward P/E of 0.00. For a more detailed relative valuation and DCF analysis to assess PomDoctor Ltd's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
0.00
Current PE
0.00
Overvalued PE
0.00
Undervalued PE
0.00

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
0.00
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
0.00
Undervalued EV/EBITDA
0.00

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
0.00
Current PS
0.00
Overvalued PS
0.00
Undervalued PS
0.00

Financials

AI Analysis
Annual
Quarterly

Related Community Screener

stocks under $1 that will be bullish today
Intellectia · 96 candidates
Price: <= $1.00
Ticker
Name
Market Cap$
top bottom
SXTC logo
SXTC
China SXT Pharmaceuticals Inc
11.70M
SAFX logo
SAFX
XCF Global Inc
28.75M
MKDW logo
MKDW
MKDWELL Tech Inc
14.59M
SRXH logo
SRXH
Srx Health Solutions Inc
11.89M
ADIL logo
ADIL
Adial Pharmaceuticals Inc
6.04M
GRI logo
GRI
GRI Bio Inc
2.26M
stocks under $0.50 with an rsi under 20
Intellectia · 33 candidates
Price: <= $0.50Rsi Category: oversold
Ticker
Name
Market Cap$
top bottom
MTEN logo
MTEN
Mingteng International Corp Inc
5.55M
ATPC logo
ATPC
Agape ATP Corp
4.10M
SXTC logo
SXTC
China SXT Pharmaceuticals Inc
11.70M
CCTG logo
CCTG
CCSC Technology International Holdings Ltd
3.84M
APLT logo
APLT
Applied Therapeutics Inc
14.63M
ZJYL logo
ZJYL
Jin Medical International Ltd
19.82M
stocks under $1 with an rsi under 20
Intellectia · 53 candidates
Price: <= $1.00Rsi Category: oversold
Ticker
Name
Market Cap$
top bottom
AIIO logo
AIIO
Robo.ai Inc
89.22M
PSTV logo
PSTV
Plus Therapeutics Inc
52.05M
HURA logo
HURA
TuHURA Biosciences Inc
41.71M
XLO logo
XLO
Xilio Therapeutics Inc
40.33M
POM logo
POM
PomDoctor Ltd
35.21M
OTLK logo
OTLK
Outlook Therapeutics Inc
32.44M
stocks under $1 with an rsi under 10
Intellectia · 53 candidates
Price: <= $1.00Rsi Category: oversold
Ticker
Name
Market Cap$
top bottom
AIIO logo
AIIO
Robo.ai Inc
89.22M
PSTV logo
PSTV
Plus Therapeutics Inc
52.05M
HURA logo
HURA
TuHURA Biosciences Inc
41.71M
XLO logo
XLO
Xilio Therapeutics Inc
40.33M
POM logo
POM
PomDoctor Ltd
35.21M
OTLK logo
OTLK
Outlook Therapeutics Inc
32.44M
stocks under $1 with an rsi under 15
Intellectia · 53 candidates
Price: <= $1.00Rsi Category: oversold
Ticker
Name
Market Cap$
top bottom
MTEN logo
MTEN
Mingteng International Corp Inc
5.55M
ATPC logo
ATPC
Agape ATP Corp
4.10M
SXTC logo
SXTC
China SXT Pharmaceuticals Inc
11.70M
CCTG logo
CCTG
CCSC Technology International Holdings Ltd
3.84M
APLT logo
APLT
Applied Therapeutics Inc
14.63M
ZJYL logo
ZJYL
Jin Medical International Ltd
19.82M
stovks to buy on wed from 20 to 40 cents
Intellectia · 81 candidates
Price: $0.20 - $0.40
Ticker
Name
Market Cap$
top bottom
SGMO logo
SGMO
Sangamo Therapeutics Inc
127.97M
IXHL logo
IXHL
Incannex Healthcare Inc
123.43M
GPUS logo
GPUS
Hyperscale Data Inc
96.48M
AURE logo
AURE
Aurelion Inc
95.26M
AIIO logo
AIIO
Robo.ai Inc
89.22M
ZONE logo
ZONE
CleanCore Solutions Inc
79.36M

Whales Holding POM

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is PomDoctor Ltd (POM) stock price today?

The current price of POM is 0.3811 USD — it has increased 1.33

What is PomDoctor Ltd (POM)'s business?

PomDoctor Ltd is a company that mainly operates an online medical services platform for chronic diseases. The Company's business model focuses on chronic disease management and pharmaceutical services, forming a one-stop medical service platform that connects patients with doctors and pharmaceutical products. It helps patients to conveniently connect with doctors and obtain one-stop medical services.

What is the price predicton of POM Stock?

Wall Street analysts forecast POM stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for POM is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is PomDoctor Ltd (POM)'s revenue for the last quarter?

PomDoctor Ltd revenue for the last quarter amounts to 16.23 USD, increased 0.12

What is PomDoctor Ltd (POM)'s earnings per share (EPS) for the last quarter?

PomDoctor Ltd. EPS for the last quarter amounts to USD, decreased

How many employees does PomDoctor Ltd (POM). have?

PomDoctor Ltd (POM) has 156 emplpoyees as of April 17 2026.

What is PomDoctor Ltd (POM) market cap?

Today POM has the market capitalization of 45.43M USD.